Brief: Kintor Pharmaceutical CFO's Long Position In H-Share Of The Company Falls To 0.59% - Filing

Kintor Pharmaceutical

10/06/2022 10:23

June 10 (Reuters) - Hong Kong stock exchange filing:
    * KINTOR PHARMACEUTICAL  9939.HK  CFO LU YAN SOLD A COMBINED
500,000 H-SHARES OF THE COMPANY ON JUNE 7-8 - HKEX FILING
    * LU'S LONG POSITION IN H-SHARE OF KINTOR PHARMACEUTICAL
REDUCED
TO 0.59% FROM 0.72% - HKEX FILING

Source text https://di.hkex.com.hk/di/NSForm3A.aspx?fn=DA20220609E00320&sa2=ns&sid=282638&sd=10/06/2021&ed=10/06/2022&sa1=cl&scsd=10/06/2021&sced=10/06/2022&sc=09939&src=Main&lang=EN&tk=ds
Source text 2 https://di.hkex.com.hk/di/NSForm3A.aspx?fn=DA20220609E00319&sa2=ns&sid=282638&sd=10/06/2021&ed=10/06/2022&sa1=cl&scsd=10/06/2021&sced=10/06/2022&sc=09939&src=Main&lang=EN&tk=ds
Further company coverage:  9939.HK 

 (Reporting by Hong Kong newsroom)
 ((twinnie.siu@tr.com; 852-3462 7715;))